Literature DB >> 25466647

MicroRNAs in virus-induced tumorigenesis and IFN system.

Gianna Fiorucci1, Maria Vincenza Chiantore2, Giorgio Mangino3, Giovanna Romeo4.   

Abstract

Numerous microRNAs (miRNAs), small non-coding RNAs encoded in the human genome, have been shown to be involved in cancer pathogenesis and progression. There is evidence that some of these miRNAs possess proapoptotic or proliferation promoting roles in the cell by negatively regulating target mRNAs. Oncogenic viruses are able to produce persistent infection, favoring tumor development by deregulating cell proliferation and inhibiting apoptosis. It has been recently suggested that cellular miRNAs may participate in host-virus interactions, influencing viral replication. Many mammalian viruses counteract this cellular antiviral defense by using viral proteins but also by encoding viral miRNAs involved in virus-induced tumorigenesis. Interferons (IFNs) modulate a number of non-coding RNA genes, especially miRNAs, that may be used by mammalian organisms as a mechanism of IFN system to combat viral infection and related diseases. In particular, IFNs might induce specific cellular miRNAs that target viral transcripts thereby using this strategy as part of their effectiveness against invading viruses. Therefore IFNs, interferon stimulated genes and miRNAs could act synergistically as innate response to virus infection to induce a potent non-permissive cellular environment for virus replication and virus-induced cancer. The relevance of this reviewed research topic is clearly related to the observation that although virus infections are responsible of specific tumors, other unidentified genetic alterations are likely involved in the induction of malignant transformation. The identification of such genetic alterations, i.e. miRNA expression in transformed cells, would be of considerable importance for the analysis of the pathogenesis and for the treatment of cancer induced by specific viruses as well as for the advancement of the current knowledge on the molecular mechanisms underlying virus-host interaction. In this respect, we will review also the important, still little explored, roles of miRNAs acting both as IFN-stimulated anti-viral molecules and as critical regulators of IFNs and IFN-stimulated genes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IFNs; MicroRNAs; Oncogenic viruses

Mesh:

Substances:

Year:  2014        PMID: 25466647     DOI: 10.1016/j.cytogfr.2014.11.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  11 in total

1.  MicroRNA-223 Promotes Type I Interferon Production in Antiviral Innate Immunity by Targeting Forkhead Box Protein O3 (FOXO3).

Authors:  Luoquan Chen; Yinjing Song; Li He; Xiaopeng Wan; Lihua Lai; Feng Dai; Yang Liu; Qingqing Wang
Journal:  J Biol Chem       Date:  2016-05-13       Impact factor: 5.157

Review 2.  Viral MicroRNAs: Interfering the Interferon Signaling.

Authors:  Imran Ahmad; Araceli Valverde; Hasan Siddiqui; Samantha Schaller; Afsar R Naqvi
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

3.  Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis.

Authors:  Maria Vincenza Chiantore; Giorgio Mangino; Marco Iuliano; Maria Simona Zangrillo; Ilaria De Lillis; Gabriele Vaccari; Rosita Accardi; Massimo Tommasino; Sandra Columba Cabezas; Maurizio Federico; Gianna Fiorucci; Giovanna Romeo
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-14       Impact factor: 4.553

4.  Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

Authors:  Yuan Fang; Yuqi Zhou; Yun Zhang; Liangliang He; Chunyi Xue; Yongchang Cao
Journal:  Oncotarget       Date:  2017-12-17

5.  MiR-451 as a new tumor marker for gastric cancer.

Authors:  Yong Shen; Jiao-Mei Gong; Li-Li Zhou; Jia-He Sheng
Journal:  Oncotarget       Date:  2017-04-19

6.  Impact of Polyunsaturated Fatty Acids on miRNA Profiles of Monocytes/Macrophages and Endothelial Cells-A Pilot Study.

Authors:  Claudia Roessler; Kevin Kuhlmann; Christine Hellwing; Anja Leimert; Julia Schumann
Journal:  Int J Mol Sci       Date:  2017-01-28       Impact factor: 5.923

7.  gga-miR-148a-5p-Targeting PDPK1 Inhibits Proliferation and Cell Cycle Progression of Avain Leukosis Virus Subgroup J (ALV-J)-Infected Cells.

Authors:  Heling Yu; Hengyong Xu; Chaoyang Yan; Shiliang Zhu; Xi Lan; Yuxiang Lu; Qijian He; Huadong Yin; Qing Zhu; Xiaoling Zhao; Diyan Li; Yiping Liu; Yan Wang
Journal:  Front Cell Dev Biol       Date:  2020-12-15

8.  Epigenetic Silencing of MicroRNA-126 Promotes Cell Growth in Marek's Disease.

Authors:  Isabelle Gennart; Astrid Petit; Laetitia Wiggers; Srđan Pejaković; Nicolas Dauchot; Sylvie Laurent; Damien Coupeau; Benoît Muylkens
Journal:  Microorganisms       Date:  2021-06-21

Review 9.  MicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune Response.

Authors:  Samuel C Forster; Michelle D Tate; Paul J Hertzog
Journal:  Front Immunol       Date:  2015-07-08       Impact factor: 7.561

10.  Common microRNA⁻mRNA Interactions in Different Newcastle Disease Virus-Infected Chicken Embryonic Visceral Tissues.

Authors:  Yan-Qing Jia; Xing-Long Wang; Xiang-Wei Wang; Chuan-Qi Yan; Chang-Jie Lv; Xiao-Qin Li; Zhi-Li Chu; Fathalrhman Eisa Addoma Adam; Sa Xiao; Shu-Xia Zhang; Zeng-Qi Yang
Journal:  Int J Mol Sci       Date:  2018-04-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.